首页工具

登录

搜索结果

Search Results for " cdk2/cyclin a "

48

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T2029	Bohemine	ERK; CDK	Cell Cycle/Checkpoint; MAPK
	Bohemine 是一种合成的选择性CDK 抑制剂，是嘌呤类似物，具有抗癌活性。它对Cdk2/cyclin E、Cdk2/cyclin A 和Cdk9/cyclin T1的IC50分别为 4.6 μM、83 μM 和 2.7 μM。
T7426	ALSTERPAULLONE	Apoptosis; GSK-3; CDK	Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
	Alsterpaullone 是高效的 CDK 抑制剂，是一种 ATP 竞争性的 GSK-3alpha/GSK-3beta 抑制剂，且作用的 IC50值都为 4 nM。它有用于神经退行性和增生性疾病的研究潜力，具有抗肿瘤活性，诱导白血病细胞凋亡。
T76377	Cdk2/Cyclin Inhibitory Peptide II
	Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL) 是一种 CDK2抑制剂，能以剂量依赖的方式杀死 U2OS 骨肉瘤细胞。
T14916	CDK2-IN-4	CDK	Cell Cycle/Checkpoint
	CDK2-IN-4 是选择性的CDK2抑制剂，对 CDK2/cyclin A 的IC50值为 44 nM，选择性高出 CDK1/cyclin B 的 2,000 倍 (IC50=86 μM)。
T15335	FN-1501	FLT; CDK	Angiogenesis; Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors
	FN-1501 是一种有效的 FLT3 和 CDK 抑制剂，具有抗肿瘤的活性，对 CDK2/cyclin A、CDK4/cyclin D1、CDK6/cyclin D1 和 FLT3 的 IC50值分别为 2.47、0.85、1.96 和 0.28 nM。
T2059	Purvalanol A NG-60	Apoptosis; CDK; Autophagy	Apoptosis; Autophagy; Cell Cycle/Checkpoint
	Purvalanol A (NG-60) 是一种CDK 抑制剂，对 cdc2-cyclin B、cdc2-cyclin B、cdk2-cyclin E、cdk4-cyclin D1 和 cdk5-p35 的IC50值分别为 4、70、35、850 和 75 nM。
T2095	Seliciclib Roscovitine,R-roscovitine,CYC202	CDK	Cell Cycle/Checkpoint
	Seliciclib (Roscovitine) 是 Cdk2/cyclin E 的有效抑制剂，IC50为0.1 µM。它还抑制 Cdk7/cyclin H、Cdk5/p35 和 Cdc2/cyclin B，IC50为 0.49、0.16和0.65 µM。
T7167	Purvalanol B NG 95,(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇	CDK; Parasite	Cell Cycle/Checkpoint; Microbiology/Virology
	Purvalanol B (NG 95) 是选择性可逆的 ATP 竞争性 CDK 抑制剂。它在一系列其他蛋白激酶 (IC50>1000 nM) 中显示出对 CDK 的选择性。它抑制耐氯喹菌株 P. falciparum 的生长。
T21588	Olomoucine	ERK; CDK	Cell Cycle/Checkpoint; MAPK
	Olomoucine 是 Cdk2/cyclin A、Cdc2/CyclinB、CDK2/CyclinE、CDK5/p35 和 ERK1/p44 MAP 激酶的 ATP 竞争性抑制剂，IC50 分别为 7、7、7、3 和 25 µM。 Olomoucine 调节细胞周期并表现出抗黑色素肿瘤活性。
T34888	TL12-186 TL12 186,TL12186	CDK; Ligand for E3 Ligase	Cell Cycle/Checkpoint; PROTAC
	TL12-186 是一种依赖于 Cereblon 的激酶降解剂，可降解 CDK，BTK，FLT3，Aurora 等激酶。TL12-186 对 CDK2/cyclin A 和 CDK9/cyclin T1 有抑制作用，IC50 分别为 73 和 55 nM。
T2378	RGB-286638 free base	GSK-3; MEK; JAK; CDK	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells
	RGB-286638 free base 是一种新型 CDK 抑制剂，抑制cyclin T1-CDK9、cyclin B1-CDK1、cyclin E-CDK2、cyclin D1-CDK4、cyclin E-CDK3和p35-CDK5活性，IC50分别为 1、2、3、4、5 和 5 nM。它也抑制 GSK-3β、TAK1、Jak2 和 MEK1，IC50值分别为 3、5、50和 54 nM。
T22260	Aminopurvalanol A	CDK	Cell Cycle/Checkpoint
	Aminopurvalanol A 是一种竞争性、选择性和细胞渗透性的Cyclins/Cdk 复合物抑制剂，优先靶向G2/M 期转变进而抑制癌细胞分化。它通过抑制生理获能依赖性肌动蛋白聚合而抑制精子受精能力。
T5200	Indirubin-3'-monoxime 靛玉红-3' -单肟,Indirubin-3'-oxime	GSK-3; Lipoxygenase; CDK	Cell Cycle/Checkpoint; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells
	Indirubin-3'-monoxime (Indirubin-3'-oxime) 是一种有效的 GSK3β 抑制剂，IC50值为 22 nM。它对 CDK5/p25、CDK1/cyclin B 和CDk2/cyclin E 也有作用，IC50值分别为 100、180 和 250 nM。
T6787	BIO-acetoxime BIA,GSK-3 Inhibitor X	Apoptosis; GSK-3; HSV	Apoptosis; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells
	BIO-acetoxime (GSK-3 Inhibitor X) 是一种 GSK3α/β 抑制剂，IC50值均为 10 nM，具有抗惊厥和抗感染作用。
T8796	CAN508	CDK	Cell Cycle/Checkpoint
	CAN508 是一种有效的 ATP 竞争性 CDK9/cyclin T1 抑制剂，IC50 为 0.35 μM。它还是 Cdk2-cyclin E 对 ATP 的竞争性抑制剂，Ki 和 IC50 值分别为 13.3 和 20 µM。它对 CDK9/cyclin T 的选择性是其他 CDK/cyclin 复合物的 38 倍，有抗肿瘤活性。
T2247	KenPaullone 9-Bromopaullone,NSC-664704,9-溴-7,12-二氢吲哚并[3,2-D][1]苯并氮杂卓-6(5H)-酮	GSK-3; CDK	Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
	KenPaullone (9-Bromopaullone) 是一种CDK1/cyclin B 和GSK-3β抑制剂，IC50值分别为 0.4 μM 和 23 nM。它也抑制 CDK2/cyclin A、CDK2/cyclin E 和 CDK5/p25 的活性，IC50值分别为 0.68 μM、7.5 μM 和 0.85 μM。。它通过增强 TGFβ-Smad3 信号通路增加和延长 foxp3 基因的转录来促进 iTreg 细胞分化。
T8463	PF-06873600	CDK	Cell Cycle/Checkpoint
	PF-06873600 是一种选择性和口服生物可利用的细胞周期蛋白依赖性激酶 (CDK) 抑制剂（CDK2、CDK4 和 CDK6，Ki 分别为 0.09 nM、0.13 nM 和 0.16 nM），具有潜在的抗肿瘤活性。
T16359	NU6140	CDK; Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	NU6140 是选择性CDK2-cyclin A 抑制剂，IC50为0.41 μM。它显示出比其他 CDK 高 10 到 36 倍的选择性。它还抑制Aurora A 和Aurora B 的活性，IC50值分别为 67 和 35 nM。它还增强细胞凋亡作用并具有抗癌活性。
T2679	BMS-265246 BMS265246	CDK	Cell Cycle/Checkpoint
	BMS-265246 是一种有效的选择性 CDK1/2 抑制剂，对 CDK1/cyclin B 和 CDK2/cyclin E 的 IC50分别为6 nM 和9 nM。
T14943	CGP60474	VEGFR; CDK; PKC	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
	CGP60474 是一种高效的抗内毒素药物，抑制细胞周期蛋白依赖激酶(CDK) ，抑制 CDK1/B、CDK2/E、CDK2/a、CDK4/D、CDK5/p25、CDK7/H 和 CDK9/T 的IC50分别为 26、3、4、216、10、200 和 13 nM。它是选择性和 ATP 竞争性PKC 抑制剂。
T4321	Indisulam E 7070	CDK; Carbonic Anhydrase	Cell Cycle/Checkpoint; Metabolism
	Indisulam (E 7070) 是碳酸酐酶抑制剂。它是细胞周期 G1期的靶向化合物，能够抑制 CDK2及周期蛋白 E 的激活，阻止 G1/S 的转化。它可以募集 DCAF15诱导RBM39降解来靶向剪接，具有抗癌作用。
T2356	Ro-3306	Apoptosis; ERK; SGK; PKA; CDK; PKC	Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; Metabolism; Tyrosine Kinase/Adaptors
	Ro 3306 是一种选择性 ATP 竞争性CDK1抑制剂，对 CDK1、CDK1/cyclin B1 和 CDK2/cyclin E 的Ki 值为分别为 20 nM、35 nM 和 340 nM。
T2615	Flavopiridol hydrochloride Alvocidib Hydrochloride,NSC 649890,MDL 107826A,HL 275,FLAVOPIRIDOL HCL,NSC 649890 HCl	HIV Protease; CDK; Autophagy	Autophagy; Cell Cycle/Checkpoint; Microbiology/Virology; Proteases/Proteasome
	Flavopiridol hydrochloride (MDL 107826A) 是一种CDK 的广谱抑制剂，与 ATP 竞争性地抑制 CDK1，CDK2 和 CDK4 的活性，IC50值分别为 30, 170, 100 nM。
T6312	R547 Ro 4584820	Apoptosis; GSK-3; PKA; CDK	Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors
	R547 (Ro 4584820) 是一种口服有效，选择性， ATP 竞争性CDK 抑制剂，对 CDK1/cyclin B、 CDK2/cyclin E 和 CDK4/cyclin D1 作用的Ki 值分别为 2 nM、3 nM、1 nM。
T22590	AT7519 TFA AT7519 trifluoroacetate	Others	Others
	AT7519 is a kinase inhibitor (IC50: 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 μM for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35).
T28434	PNU-292137 PNU 292137
	PNU-292137 is an inhibitor of CDK2/cyclin A with the activity of antitumor.
T21377	Aloisine A
	Aloisine A is a potent and selective CDK/GSK-3 inhibitor. IC50 data of Aloisine A: Cdk1/cyclin B (IC50: 150nM), Cdk2/cyclin A (IC50: 120nM), Cdk2/cyclin E (IC50: 400nM), Cdk5/p25 (IC50: 200nM), Cdk5/p35 (IC50: 160nM), GSK-3α (IC50: 500nM), GSK-3β (IC50: 6
T11653	Indirubin-5-sulfonate	Others	Others
	Indirubin-5-sulfonate shows inhibitory activity against GSK-3β. Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1,
T2082	CDK4-IN-1	CDK	Cell Cycle/Checkpoint
	CDK4-IN-1 是一种新型的特异性 CDK4/Cyclin D1 抑制剂，IC50 为 10 nM；分别是 CDK1/Cyclin B (IC50>15 uM) 和 CDK2/Cyclin A (IC50=5.265 uM) 的 1500 倍和 500 倍。
T21950	K 00546
	K00546 是一种有效的细胞周期蛋白依赖性激酶CDK1和CDK2抑制剂，对CDK1/cyclin B 和CDK2/cyclin A 的IC50分别为 0.6 nM 和 0.5 nM。K00546 也是一种有效的 CDC2 样激酶 1 (CLK1) 和CLK3抑制剂，IC50分别为 8.9 nM 和 29.2 nM。
T61890	(E/Z)-BIO-acetoxime
	(E/Z)-BIO-acetoxime 是有效的，选择性的GSK-3α/β 抑制剂。对于GSK-3α/β，CDK5/p25，CDK2/cyclin A 和CDK1/cyclin B 的IC50分别为10nM，2.4μM, 4.3μM, 63μM。
T63362	Ulecaciclib
	Ulecaciclib 是口服具有活力的、能够透过血脑屏障的、表现出良好的药代动力学特征的细胞周期蛋白依赖激酶 (CDK) 抑制剂，对CDKs 的ki 为 0.62 μM (CDK2/Cyclin A)、3 nM (CDK6/Cyclin D3) 、0.2 nM (CDK4/Cyclin D1)和 0.63 μM (CDK7/Cyclin H)。
T69311	GW300657X
	GW300657X is a small molecule inhibitor that blocks toxoplasma gondii rhoptry kinase 18 and maintains moderate CDK2-cyclin A inhibitory activity.
T60154	CDK2-IN-13
	CDK2-IN-13 是一种有效的 Cyclin-dependent kinase 2（CDK2）抑制剂(IC50 值: 12 µM) 。CDK2-IN-13 参与细胞周期的调节，可使细胞周期停滞.。CDK2-IN-13可阻止细胞的分裂和增殖，诱导细胞凋亡，可用于癌症的研究。
T40290	CDK12-IN-5 CDK12-IN-5
	CDK12-IN-5 is a pyrazolotriazine compound that effectively inhibits CDK12, with an IC50 value of 23.9 nM at a high ATP concentration of 2 mM. However, CDK12-IN-5 does not exhibit inhibitory effects on CDK2/Cyclin E (IC50 = 173 μM) and CDK9/Cyclin T1 (IC50 = 127 μM) at the same high ATP concentration of 2 mM, as stated in WO2021116178A1.
T40288	CDK12-IN-4 CDK12-IN-4
	CDK12-IN-4, a pyrazolotriazine compound, exhibits potent inhibition of CDK12 by achieving an IC50 value of 0.641 μM, utilizing high ATP levels (2 mM). Notably, CDK12-IN-4 does not impact CDK2/Cyclin E (IC50 > 20 μM) or CDK9/Cyclin T1 (IC50 > 20 μM) under the influence of high ATP (2 mM) levels (WO2021116178A1).
T73196	RGB-286638
	RGB-286638 是一种有效的 CDK 抑制剂，抑制cyclin T1-CDK9，cyclin B1-CDK1，cyclin E-CDK2，cyclin D1-CDK4，cyclin E-CDK3和p35-CDK5活性，IC50分别为 1，2，3，4，5 和 5 nM；同时可抑制GSK-3β，TAK1，Jak2和MEK1，IC50值分别为 3，5，50，和 54 nM。
T40546	3-Methylthienyl-carbonyl-JNJ-7706621
	3-Methylthienyl-carbonyl-JNJ-7706621 is a highly potent and selective inhibitor of cyclin-dependent kinase (CDK). It exhibits impressive IC50 values of 6.4 nM and 2 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. Additionally, 3-Methylthienyl-carbonyl-JNJ-7706621 demonstrates potent inhibition against GSK-3 (IC50 = 0.041 μM) and moderate potency towards CDK4, VEGF-R2, and FGF-R2 (IC50 = 0.11 μM, 0.13 μM, and 0.22 μM, respectively). Its applications in cancer research are noteworthy.
T40289	CDK12-IN-6 CDK12-IN-6
	CDK12-IN-6, a pyrazolotriazine compound, is a powerful inhibitor of CDK12. Its inhibitory activity is significant with an IC50 value of 1.19 μM when tested at high ATP concentration (2 mM). Notably, CDK12-IN-6 does not exhibit any inhibitory effect on CDK2/Cyclin E (IC50 >20 μM) and CDK9/Cyclin T1 (IC50 >20 μM) when tested under the same high ATP conditions (2 mM) (WO2021116178A1).
T72885	Akt1&PKA-IN-1
	Akt1&PKA-IN-1 是一种有效的Akt/PKA 双重抑制剂，对 PKAa、Akt 和CDK2的IC50值分别为 0.03、0.11 μM 和 9.8 μM。Akt1&PKA-IN-1 对细胞周期蛋白依赖性激酶 2 (CDK2) 具有选择性。
T39943	CDK7-IN-6 CDK7-IN-6
	CDK7-IN-6 is a highly effective and specific inhibitor (IC50 ≤100 nM) of cyclin-dependent kinase 7 (CDK7). It showcases remarkable selectivity, with more than a 200-fold preference for CDK7 over CDK1, CDK2, and CDK5. This compound holds significant potential for cancer research purposes.
T72886	Akt1&PKA-IN-2
	Akt1&PKA-IN-2 ((R)-29) 是一种具有周期蛋白依赖性激酶 2 (CDK2) 选择性的酰胺类 PKB/AKT 抑制剂。Akt1&PKA-IN-2 抑制 AKT1、PKAa 和 CDK2a，IC50值分别为 0.007 µM、0.01 µM 和 0.69 µM。
T62695	GFB-12811
	GFB-12811，一种具有高选择性的口服活性CDK5抑制剂，其IC50为2.3 nM。该化合物对其他CDK激酶(CDK1/2/6/7/9)表现出显著的选择性。
T73163	CDK7-IN-20
	CDK7-IN-20 是一种有效的、选择性的、不可逆的 CDK7(CDK) 抑制剂，IC50值为 4 nM。CDK7-IN-20 对 CDK7的选择性超过 CDK1、CDK2、CDK3、CDK5、CDK6、CDK9 和 CDK12的 206 倍以上。CDK7-IN-20 具有用于常染色体显性多囊肾病 (ADPKD) 研究的潜力。
T69196	AG-012986
	AG-012986 is a multitargeted cyclin-dependent kinase (CDK) inhibitor active against CDK1, CDK2, CDK4/6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. AG-012986 showed antiproliferative activities in vitro with IC(50)s of <100 nmol/L in 14 of 18 tumor cell lines. In vivo, significant antitumor efficacy induced by AG-012986 was seen (tumor growth inhibition, >83.1%) in 10 of 11 human xenograft tumor models. AG-012986 also showed dose-dependent retinoblastoma Ser(795) hy...
T69197	AG-012986 HCl
	AG-012986 HCl is a multitargeted cyclin-dependent kinase (CDK) inhibitor active against CDK1, CDK2, CDK4/6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. AG-012986 HCl showed antiproliferative activities in vitro with IC(50)s of <100 nmol/L in 14 of 18 tumor cell lines. In vivo, significant antitumor efficacy induced by AG-012986 HCl was seen (tumor growth inhibition, >83.1%) in 10 of 11 human xenograft tumor models. AG-012986 HCl also showed dose-dependent retinoblas...
T62235	CDK-IN-9
	CDK-IN-9 (compound 24) 是一种 CDK 的有效抑制剂。CDK-IN-9 也是一种能够诱导 CDK12 和 DDB1 相互作用的分子胶，能够作用于 CDK2/E (IC50: 4 nM) 。CDK-IN-9 能够导致细胞周期蛋白 K (cyclin K) 的多泛素化及其随后的降解。CDK-IN-9 可以利用去磷酸化视网膜母细胞瘤蛋白和RNA 聚合酶 II，进而诱导细胞凋亡 (apoptosis)。
T35525	PI3-Kinase α Inhibitor 2 PI3-Kinase α Inhibitor 2
	Phosphatidylinositol 3-kinase (PI3K) catalyzes the phosphorylation of the 3' hydroxyl position of PIs to produce the second messengers PtdIns-(3,4)-P2 and PtdIns-(3,4,5)-P3. PI3Kα, β, and δ are class 1A enzymes composed of p110 and p85 subunits, whereas PI3Kγ is a class 1B PI3K composed of a p110 catalytic subunit and a p101 or p84 regulatory subunit. PI3Kα inhibitor 2 is a selective inhibitor of PI3Kα with IC50 values of 2, 16, 660, and 220 nM for the α, β, γ, and 2Cβ isoforms, respectively. It...

化合物

Cat.No: T2029

Target: ERK, CDK

Cat.No: T7426

Target: Apoptosis, GSK-3, CDK

Cdk2/Cyclin Inhibitory Peptide II

Cat.No: T76377

Cat.No: T14916

Target: CDK

Cat.No: T15335

Target: FLT, CDK

Cat.No: T2059

Synonym: NG-60

Target: Apoptosis, CDK, Autophagy

Cat.No: T2095

Synonym: Roscovitine,R-roscovitine,CYC202

Target: CDK

Cat.No: T7167

Synonym: NG 95,(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇

Target: CDK, Parasite

Cat.No: T21588

Target: ERK, CDK

Cat.No: T34888

Synonym: TL12 186,TL12186

Target: CDK, Ligand for E3 Ligase

RGB-286638 free base

Cat.No: T2378

Target: GSK-3, MEK, JAK, CDK

Aminopurvalanol A

Cat.No: T22260

Target: CDK

Indirubin-3'-monoxime

Cat.No: T5200

Synonym: 靛玉红-3' -单肟,Indirubin-3'-oxime

Target: GSK-3, Lipoxygenase, CDK

Cat.No: T6787

Synonym: BIA,GSK-3 Inhibitor X

Target: Apoptosis, GSK-3, HSV

Cat.No: T8796

Target: CDK

Cat.No: T2247

Synonym: 9-Bromopaullone,NSC-664704,9-溴-7,12-二氢吲哚并[3,2-D][1]苯并氮杂卓-6(5H)-酮

Target: GSK-3, CDK

Cat.No: T8463

Target: CDK

Cat.No: T16359

Target: CDK, Aurora Kinase

Cat.No: T2679

Synonym: BMS265246

Target: CDK

Cat.No: T14943

Target: VEGFR, CDK, PKC

Cat.No: T4321

Synonym: E 7070

Target: CDK, Carbonic Anhydrase

Cat.No: T2356

Target: Apoptosis, ERK, SGK, PKA, CDK, PKC

Flavopiridol hydrochloride

Cat.No: T2615

Synonym: Alvocidib Hydrochloride,NSC 649890,MDL 107826A,HL 275,FLAVOPIRIDOL HCL,NSC 649890 HCl

Target: HIV Protease, CDK, Autophagy

Cat.No: T6312

Synonym: Ro 4584820

Target: Apoptosis, GSK-3, PKA, CDK

Cat.No: T22590

Synonym: AT7519 trifluoroacetate

Target: Others

Cat.No: T28434

Synonym: PNU 292137

Cat.No: T21377

Indirubin-5-sulfonate

Cat.No: T11653

Target: Others

Cat.No: T2082

Target: CDK

Cat.No: T21950

(E/Z)-BIO-acetoxime

Cat.No: T61890

Cat.No: T63362

Cat.No: T69311

Cat.No: T60154

Cat.No: T40290

Synonym: CDK12-IN-5

Cat.No: T40288

Synonym: CDK12-IN-4

Cat.No: T73196

3-Methylthienyl-carbonyl-JNJ-7706621

Cat.No: T40546

Cat.No: T40289

Synonym: CDK12-IN-6

Cat.No: T72885

Cat.No: T39943

Synonym: CDK7-IN-6

Cat.No: T72886

Cat.No: T62695

Cat.No: T73163

Cat.No: T69196

Cat.No: T69197

Cat.No: T62235

PI3-Kinase α Inhibitor 2

Cat.No: T35525

Synonym: PI3-Kinase α Inhibitor 2

Cat. No.	Product Name	Target	Signaling Pathways
T6S1487	Ginsenoside Rg5 人参皂苷Rg5,人参皂甙 Rg5	NF-κB; COX; IGF-1R	Immunology/Inflammation; Neuroscience; NF-κB; Tyrosine Kinase/Adaptors
	Ginsenoside Rg5 是红参的主要成分，可阻断IGF-1与其受体的结合，IC50约为90 nM。它还通过抑制NF-κB p65的 DNA 结合活性来抑制COX-2的 mRNA 表达。它可促进血管生成和改善高血压，具有抗炎和治疗阿尔茨海默病的潜力。

天然产物

Ginsenoside Rg5

Cat.No: T6S1487

Synonym: 人参皂苷Rg5,人参皂甙 Rg5

Target: NF-κB, COX, IGF-1R

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼